Comparison of oral nicotinamide adenine dinucleotide (NADH) versus conventional therapy for chronic fatigue syndrome.
Santaella ML et al. (2004) Comparison of oral nicotinamide adenine […]
Research Papers
Olmesartan alleviates symptoms of chronic fatigue syndrome in mice.
Olmesartan alleviates symptoms of chronic fatigue syndrome in mice. Read More »
Saqulain S et al. (2022) Olmesartan alleviates symptoms of chronic
Alpha Interferon Treatment of Patients with Chronic Fatigue Syndrome.
Alpha Interferon Treatment of Patients with Chronic Fatigue Syndrome. Read More »
See DM and Tilles JG . (1996) Alpha Interferon Treatment
Long-term treatment is being used
Long-term treatment is being used Read More »
Shepherd C . (1997) Long-term treatment is being used .
Treatment of chronic fatigue syndrome with 5-HT3 receptor antagonists preliminary results.
Sp�th M et al. (2000) Treatment of chronic fatigue syndrome
Hypothesis: Mechanisms That Prevent Recovery in Prolonged ICU Patients Also Underlie Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Stanculescu D et al. (2021) Hypothesis: Mechanisms That Prevent Recovery
Muscle injections with lidocaine improve resting fatigue and pain in patients with chronic fatigue syndrome.
Staud R ,, et al. (2017) Muscle injections with lidocaine
Rituximab Therapy for Primary Sjögren’s Syndrome: An Open-Label Clinical Trial and Mechanistic Analysis.
St. Clair EW et al. (2013) Rituximab Therapy for Primary
Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome.
Steinberg P et al. (1996) Double-blind placebo-controlled study of the
A Controlled Clinical Trial with a Specifically Configured RNA Drug, Poly(I). Poly(C12U), in Chronic Fatigue Syndrome.
Strayer DR et al. (1994) A Controlled Clinical Trial with
A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome.
Strayer DR et al. (2012) A Double-Blind, Placebo-Controlled, Randomized, Clinical
Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Strayer Dr et al. (2020). Effect of disease duration in
Acyclovir Treatment of the Chronic Fatigue Syndrome. Lack of efficacy in a placebo-controlled trial.
Straus SE et al. (1988) Acyclovir Treatment of the Chronic
Pharmacological significance of MitoQ in ameliorating mitochondria-related diseases.
Pharmacological significance of MitoQ in ameliorating mitochondria-related diseases. Read More »
Sulaim on LA et al. (2022) Pharmacological significance of MitoQ
Pharmacological management of neuropathic pain in non-specialist settings: summary of NICE guidance.
Tan T et al. (2010) Pharmacological management of neuropathic pain
The Use of D-Ribose in Chronic Fatigue Syndrome and Fibromyalgia: A Pilot Study.
The Use of D-Ribose in Chronic Fatigue Syndrome and Fibromyalgia: A Pilot Study. Read More »
Teitelbaum JE et al. (2006) The Use of D-Ribose in
Recovery from chronic fatigue syndrome with modafinil.
Recovery from chronic fatigue syndrome with modafinil. Read More »
Turkington D et al. (2004) Recovery from chronic fatigue syndrome
Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial.
Vaucher P et al. (2012) Effect of iron supplementation on
Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome (1996a)
Vercoulen JH et al. (1996a) Randomised, double-blind, placebo-controlled study of